Drugs / CS10BR05
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03265444 | Apr 2018 → Dec 2019 | multiple system atrophy | Corestemchemon, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS10BR05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03265444 ↗ |
| Modality | Cell therapy | “autologous bone marrow-derived mesenchymal stem cells(CS10BR05)” NCT03265444 ↗ |
| Route | Other | “carotid artery(intra-arterial) injection” NCT03265444 ↗ |